International expert consensus statements on surgery for T2DM
An International panel of experts has published 43 statements on the nature, terminology and mechanisms of action of metabolic and...
top of page
Headlines
Ring-augmented RYGB in patients with BMI≥50 leads to significant weight loss and improvement in obesity-related complications
Ring-augmented RYGB (raRYGB) with a MiniMizer Ring in patients with BMI≥50kg/m2, results in significant weight loss and improvements in...
Research
MBS may improve depression, anxiety and non-normative eating, but slightly increase suicides and substance use disorders
Metabolic and bariatric surgery (MBS) may improve depression, anxiety, non-normative eating, and attention, but slightly increase...
First participants dosed in Ascletis’ 13-week Phase IIa study of oral GLP-1r agonist ASC30
The first participants with obesity or overweight with at least one weight-related comorbidity have been dosed in Ascletis Pharma’s US...
Ring-augmented RYGB in patients with BMI≥50 leads to significant weight loss and improvement in obesity-related complications
Ring-augmented RYGB (raRYGB) with a MiniMizer Ring in patients with BMI≥50kg/m2, results in significant weight loss and improvements in...
Journal Watch 2/7/2025
Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
International expert consensus statements on surgery for T2DM
An International panel of experts has published 43 statements on the nature, terminology and mechanisms of action of metabolic and...
Rerouted bile acid reduces tumour spread in colorectal cancer mouse model
Bile acid diversion in Roux-en-Y gastric bypass (RYGB) reduces colorectal tumour growth and metastasis independent of weight loss,...
Protagonist selects PN-477 an oral and injectable triple agonist peptide development candidate for obesity
Protagonist Therapeutics has selected PN-477 a novel oral peptide - PN-477o with once-daily dosing, high potency and activation of...
First dual GCG/GLP-1ra gains approval from China’s NMPA for chronic weight management
China's National Medical Products Administration (NMPA) has approved Innovent Biologics’ mazdutide, a first-in-class dual glucagon...
Qaelon Medical establishes Data Advisory Board to detect, prevent and predict surgical leaks
Qaelon Medical has announced the formation of its Data Advisory Board (DAB) dedicated exclusively to data-driven detection, prevention...
New drug lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass
A new potential drug lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass, according to a...
Only one in 12 remain on a GLP-1 drug for obesity at three years
Only 8% of individuals (or one in 12) initiating a glucagon-like peptide-1 (GLP-1) agonist drug for obesity without diabetes continued to...
Increase in number of cases of acute and chronic pancreatitis linked to GLP-1 medicines
Data from the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has revealed that since...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
3rd Annual International Symposium on Magnetic Gastrointestinal and Colon Surgery
Tweets
bottom of page